Immune system cancer is a group of cancers that start in cells that normally fight infection, such as white blood cells or lymph tissue. Early symptoms of immune system cancer can include swollen lymph nodes, tiredness, fevers, night sweats, frequent infections, or unexplained weight loss. Many people first hear about immune system cancer after symptoms last for weeks or months, though some types are found during routine blood tests. It can affect children or adults, and the outlook varies a lot by the exact type and stage. Treatment often includes chemotherapy, targeted drugs, immunotherapy, radiation, or stem cell transplant, and some immune system cancers can be cured while others are managed over time.
How many people live with Immune system cancer?
There is no single official count for "immune system cancer" because this lay term usually includes several cancers of blood and immune cells, such as lymphoma, leukemia, and myeloma. Adding those main cancer groups suggests that about 4 million people worldwide were alive within 5 years of diagnosis (Global Cancer Observatory, 2022), and about 1.72 million people in the United States are living with or are in remission from leukemia, lymphoma, or myeloma (Leukemia & Lymphoma Society, 2024).
Overview
Immune system cancerSymptoms
Immune system cancer can cause swollen lymph nodes, fatigue, fever, night sweats, and unexplained weight loss. Some people also notice frequent infections, easy bruising, or bone pain. Early symptoms of immune system cancer can vary by type.
Outlook and prognosis
The outlook for immune system cancer varies by type, stage, and how well it responds to treatment. Many people with immune system cancer do well for years, especially when it is found early and closely monitored.
Causes and risk factors
Immune system cancer risk rises with age, certain inherited gene changes, immune suppression, past radiation or chemotherapy, some infections, and exposure to chemicals like benzene. Smoking and obesity may raise risk for some immune system cancers.
Genetic influences
Genetics can matter in immune system cancer, but most cases are not directly inherited. Certain DNA changes may raise risk or shape how the cancer behaves, while others happen during life rather than being passed down.
Diagnosis
Immune system cancer is diagnosed with a medical history, physical exam, blood tests, imaging, and often a biopsy. The diagnosis of immune system cancer depends on the cancer type and where it starts.
Treatment and drugs
Treatment for immune system cancer depends on the exact type and stage, and may include chemotherapy, targeted drugs, immunotherapy, radiation, or stem cell transplant. Many people also need medicines to prevent infections, ease symptoms, and support blood counts during treatment.
Symptoms
Immune system cancer often shows up as changes that can seem vague at first, such as tiredness, swollen glands, or repeated infections. You might notice small changes at first, like needing more rest than usual or finding a lump in the neck, armpit, or groin that does not go away. The symptoms can differ depending on the exact type of immune system cancer, but several warning signs tend to come up again and again. Not every one of these problems means cancer, but ongoing or unexplained changes deserve medical attention.
Painless swelling in the neck, armpits, or groin is a common sign, especially when lymph nodes are involved. The lump may stay the same for weeks or slowly get bigger instead of fading after a short illness.
Many people with immune system cancer feel unusually worn out, even after sleep or a quiet day. This kind of fatigue can make work, exercise, or routine chores feel much harder than usual.
Ongoing fevers without a clear cause can happen, and some people wake up with drenching night sweats. In daily routines, this might show up as needing to change clothes or bed sheets during the night.
Unplanned weight loss can happen even when eating habits have not changed much. Some people also notice a lower appetite or feel full quickly.
How people usually first notice Immune system cancer?
Many people first notice immune system cancer when a swollen lymph node does not go away, often in the neck, armpit, or groin, or when they start feeling unusually tired for weeks without a clear reason. Early warning signs can also include fevers, drenching night sweats, unexplained weight loss, easy bruising, or infections that keep coming back, although symptoms vary depending on the type of cancer. Because these changes are common in many noncancerous illnesses too, the pattern that stands out is usually that the symptoms persist, return, or gradually build instead of improving as expected.
Types of Immune system cancer
Immune system cancer is not one single disease. It is a broad term for cancers that affect infection-fighting cells, the bone marrow, or the lymph system, so the main types of immune system cancer can look quite different in daily life. Some people notice swollen glands and fevers, while others feel wiped out, bruise easily, or have repeated infections. Symptoms don’t always look the same for everyone.
Lymphoma
This type starts in lymphocytes, a kind of white blood cell, and often shows up as swollen lymph nodes, fevers, night sweats, or weight loss. Many living with lymphoma first notice a lump in the neck, armpit, or groin that does not go away. There are two main groups, Hodgkin lymphoma and non-Hodgkin lymphoma, and symptoms and treatment can differ between them.
Leukemia
This type begins in the bone marrow and blood, where abnormal white blood cells crowd out healthy cells. For many, this can mean frequent infections, unusual bruising or bleeding, tiredness, or feeling short of breath during ordinary activities like climbing stairs. Leukemia can be acute, meaning it develops quickly, or chronic, meaning it often grows more slowly.
Myeloma
This cancer affects plasma cells, which normally help make antibodies to fight germs. People with myeloma may have bone pain, weakness, repeated infections, or kidney problems, and some find that back or rib pain becomes hard to ignore. Doctors often call this multiple myeloma because it commonly involves more than one area of bone marrow.
Can I slow down the onset of symptoms?
Not really—there is no proven lifestyle change or medicine that can reliably slow the start of most cancers of the immune system, such as lymphoma, leukemia, or myeloma. Healthy habits like not smoking, limiting contact with harmful chemicals when possible, keeping infections such as HIV well treated, and avoiding medicines that weaken the immune system unless they are truly needed may lower risk for some people, but lowering risk is not the same as preventing the cancer or delaying symptoms for sure. There is no routine screening test for most people, but regular checkups and getting lasting swollen glands, unusual bruising, frequent infections, or unexplained weight loss checked early can still make a real difference.
What genetics can tell you about symptoms
Genetics can sometimes help explain why immune system cancers, such as lymphoma or myeloma, behave differently from one person to another, including which symptoms show up, how fast they develop, and how severe they become. Certain gene changes in the cancer cells can be linked with patterns like swollen lymph nodes, fevers, night sweats, weight loss, bone pain, or repeated infections, but genes alone do not predict exactly what someone will feel day to day. In some families, inherited genetic changes can also raise the chance of developing these cancers at a younger age, although many people with immune system cancer have no known inherited cause.
Causes and risk factors
Immune system cancer usually develops from a mix of genetic changes and life exposures that build up over time. Risk often rises with older age, a weakened immune system, and some long-lasting infections or autoimmune conditions. Family history can be one part of the story, but lifestyle and environment add their own chapters. Exposure to some chemicals, high doses of radiation, smoking, and excess body weight may also raise the risk of immune system cancer. Many people with these risk factors never develop immune system cancer, but a doctor can help you understand your personal risk.
What are the most common causes or risk factors?
The exact cause of immune system cancers, such as many lymphomas, is often not clear, but the risk is higher with older age, a family history of these cancers, and certain gene changes that build up in immune cells over time. Risk also goes up in people living with a weakened immune system, including after an organ transplant, with HIV, or with long-term medicines that suppress the immune system. Some viral infections, certain autoimmune diseases, and exposure to high levels of radiation or some chemicals can also raise the risk.
Environmental and biological risk factors
Immune system cancer is more likely in some situations than others, although having a risk factor does not mean you will develop it. Doctors often group risks into internal (biological) and external (environmental). The exact pattern depends on the subtype, but understanding the risk factors for immune system cancer can make it easier to know when closer follow-up may be helpful.
Many cancers of the immune system become more common with age, especially after midlife. This is partly because immune cells have had more time to build up changes, and the body may be less able to clear abnormal cells.
People with HIV or those taking anti-rejection medicine after an organ transplant have a higher risk of immune system cancer. When immune defenses are suppressed for a long time, abnormal immune cells are more likely to survive and grow.
Some long-lasting infections are linked to specific immune system cancers. These include Epstein-Barr virus, hepatitis C, a rare virus called HTLV-1, and Helicobacter pylori, a stomach infection.
Conditions such as rheumatoid arthritis, lupus, Sjogren disease, and celiac disease can keep the immune system activated for years. That ongoing inflammation may raise the risk of some cancers that start in immune cells.
Genetic risk factors
For many living with immune system cancer, one of the first questions is whether it runs in the family. Most cases are linked to gene changes that develop inside immune cells over time rather than a single inherited cause. Carrying a genetic change doesn’t guarantee the condition will appear. When people ask about genetic risk factors for immune system cancer, the answer is usually a mix of rare inherited conditions, family history, and non-inherited DNA changes in the cancer cells themselves.
Acquired mutations: Many immune system cancers begin when white blood cells pick up DNA mistakes that let them grow when they should stop. These changes are usually not inherited, so they are present in the cancer cells rather than in every cell of the body.
Family history: Having a close relative with lymphoma, leukemia, myeloma, or a similar blood cancer can slightly raise the chance of immune system cancer. This pattern suggests shared inherited traits in some families, but most relatives will never develop cancer.
Inherited syndromes: A small number of people inherit rare conditions that make the immune system develop or work abnormally from birth. These syndromes can increase the risk of immune system cancer because immune cells are less able to control growth and repair damage.
DNA repair genes: Some rare inherited gene changes affect how the body fixes damaged DNA. When repair is weaker, genetic mistakes can build up more easily in immune cells and raise cancer risk.
Chromosome changes: Doctors often find extra, missing, or rearranged pieces of chromosomes in immune system cancer cells. These changes can switch growth signals on or off, helping the cancer cells survive and multiply.
Lifestyle risk factors
Some lifestyle habits may influence the risk of cancers that affect the immune system, such as lymphoma and certain blood cancers, although the effects are often less direct than in lung or colon cancer. The strongest evidence points to tobacco use, excess body weight, low physical activity, and patterns that increase chronic inflammation or weaken immune health. When people ask about lifestyle risk factors for immune system cancer, it is most accurate to think in terms of habits that may raise risk or worsen overall resilience rather than a single cause. These factors do not explain every case, but they can meaningfully affect long-term health.
Tobacco use has been linked to a higher risk of some lymphomas and other blood-related cancers. It can promote chronic inflammation, DNA damage, and weaker immune surveillance that may support cancer development.
Obesity is associated with a higher risk of several cancers, including some immune system cancers. Extra body fat can alter hormone signaling and keep the body in a state of chronic low-grade inflammation.
Regular physical activity helps with weight control, insulin balance, and inflammation levels. Too little exercise may indirectly raise immune system cancer risk by worsening these cancer-related pathways.
Diets high in ultra-processed foods, added sugars, and excess calories can contribute to obesity and metabolic dysfunction. A low intake of fruits, vegetables, fiber, and other nutrient-dense foods may also reduce support for normal immune and cellular health.
Risk prevention
Many people worry about whether immune system cancer can be prevented, but for most blood and lymph system cancers, there is no sure way to stop them from developing. What you can do is lower avoidable risks, protect your immune system, and keep up with medical care that may catch problems earlier. Prevention is about lowering risk, not eliminating it completely. This matters because early symptoms of immune system cancer, such as ongoing swollen glands, unusual fatigue, or repeated infections, can be easy to brush off at first.
Not smoking helps lower the risk of several cancers, including some that affect the blood and immune system. If you smoke now, quitting still helps because risk can fall over time.
Long-term contact with benzene, certain solvents, pesticides, and other industrial chemicals may raise the risk of some immune system cancers. Use workplace protection carefully and follow safety guidance if you work around these substances.
Unnecessary exposure to high-dose radiation can increase cancer risk over time. Medical imaging is often important, but it is reasonable to ask whether a scan is truly needed and whether a lower-radiation option is available.
Some infections linked to lymphoma and other immune system cancers are harder to avoid completely, but reducing exposure still matters. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise.
Can you prevent Immune system cancer?
No, you cannot fully prevent immune system cancer, and many people who develop it have no clear cause they could have avoided. For some types, risk may be lowered by not smoking, avoiding harmful chemical or radiation exposure when possible, and preventing or treating certain infections such as HIV and hepatitis C. Even so, these steps cannot guarantee prevention.
Transmission
Immune system cancer is not infectious, which means it does not spread from person to person through hugging, kissing, coughing, sex, or sharing food, drinks, or bathrooms. If you are wondering whether immune system cancer can spread from person to person, the answer is no in everyday life.
Many living with immune system cancer also worry about family members, but these cancers are usually not directly passed down in a simple way, even though some families may share a higher risk. In very rare medical situations, such as an organ transplant from a donor with an undetected cancer, transfer has been reported, but this is not how immune system cancer spreads for almost everyone.
When to test your genes
If you have an immune system cancer, genetic testing is usually most useful after diagnosis to guide treatment, predict response, and sometimes clarify prognosis. Testing may also matter earlier if you have a strong family history of blood or immune cancers, very early-onset disease, or unusual repeated cancers.
Diagnosis
People with immune system cancer are often diagnosed after symptoms such as swollen lymph nodes, unusual tiredness, repeated infections, easy bruising, or unexplained weight loss lead to a medical visit. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of immune system cancer usually combines an exam, blood work, imaging, and a sample of abnormal cells or tissue.
Doctors ask about symptoms, how long they have been happening, and any pattern of fevers, night sweats, infections, bleeding, or weight loss. A detailed family and health history can help point to likely causes and guide the next tests.
Your doctor checks for swollen lymph nodes in the neck, armpits, or groin and may also feel for an enlarged liver or spleen. They also look for signs such as paleness, bruising, or infection that can suggest blood or lymph system disease.
Blood work can show abnormal numbers of white blood cells, red blood cells, or platelets, and it may reveal how well the kidneys and liver are working. Other lab tests may help rule out common conditions and show whether immune system cancer is affecting the blood.
Scans such as CT, PET, MRI, or ultrasound can look for enlarged lymph nodes, tumors, or spread to other parts of the body. These imaging findings help doctors see where the disease is and choose the best place to take a biopsy.
How is Immune system cancer diagnosed?
Immune system cancers are usually diagnosed with a mix of a medical history, a physical exam, blood tests, and imaging tests such as a CT scan or PET scan to look for swollen lymph nodes or other signs of disease. In many cases, the key step is taking a small sample of a lymph node, bone marrow, blood, or another affected area and checking it under a microscope to confirm cancer and find the exact type. Sometimes doctors also use genetic or cell tests on that sample to help classify the cancer more precisely and guide treatment.
Stages of Immune system cancer
Immune system cancer does not have defined progression stages. This is because it is a broad group of cancers, and different types such as lymphoma, leukemia, and myeloma are tracked in different ways rather than following one shared step-by-step pattern. Often the process begins when you notice changes in daily life, such as unusual tiredness, swollen glands, frequent infections, or other early symptoms of immune system cancer, and a doctor then uses blood tests, scans, and sometimes a biopsy to find the cause. Monitoring usually depends on the exact cancer type and may include repeat blood work, imaging, bone marrow tests, and regular checkups to see how active the disease is and how well treatment is working.
Outlook and prognosis
The outlook for immune system cancers varies widely depending on the specific cancer type, how advanced it is at diagnosis, the person’s age and overall health, and how well the disease responds to treatment. Many blood and lymphatic cancers that affect the immune system, such as some lymphomas and leukemias, can be controlled for years, and some are curable, especially when found early or when they respond well to modern therapies. Others can behave more aggressively, relapse after treatment, or become resistant, which can worsen prognosis. Survival has improved in recent years because of targeted drugs, immunotherapy, stem cell transplantation, and better supportive care. Mortality ranges from low for certain slow-growing forms to substantial for aggressive or advanced disease, so doctors usually estimate prognosis using the exact diagnosis rather than the broad term immune system cancer. Regular follow-up is important because even after remission, some immune system cancers can return or lead to long-term treatment-related complications.
Long-term effects
For many people, the long-term effects of immune system cancer come from both the cancer itself and the treatments used to control it. Long-term effects vary widely, depending on the exact type of immune system cancer, a person’s age, and whether the disease stays in remission or comes back. Some people return to most of their usual routine, while others live with ongoing fatigue, infections, nerve problems, or organ-related complications for years.
Deep tiredness can last long after treatment ends and may affect work, exercise, and daily tasks. Many living with immune system cancer describe needing more rest than they used to, even on otherwise good days.
Some immune system cancers and their treatments weaken normal immune defenses for months or years. This can mean more frequent infections, slower recovery from common illnesses, and a greater need to watch for fever or other early signs of infection.
Low red cells, white cells, or platelets can continue over time in some people with immune system cancer. This may lead to tiredness, easy bruising, bleeding, or repeated infections.
Certain treatments can leave lasting numbness, tingling, burning pain, or weakness in the hands and feet. For many, symptoms improve slowly, but some nerve changes can be long lasting.
How is it to live with Immune system cancer?
Living with immune system cancer can feel like daily life has become less predictable, because fatigue, frequent infections, pain, swollen lymph nodes, or the effects of treatment may change what you can do from one day to the next. Many living with these cancers need more rest, more medical visits, and extra care around crowds or illness, which can affect work, school, travel, and family routines. The people around you often adjust too, taking on caregiving roles, helping with transportation or meals, and carrying emotional stress as they try to support you. Even so, many people with immune system cancer find that clear communication, practical help, and a strong care team make everyday life more manageable and less isolating.
Treatment and drugs
Immune system cancer is usually treated with a mix of therapies, and the plan depends on the exact type of cancer, where it is in the body, how fast it is growing, and your overall health. Treatment often looks different for each person, but common options include chemotherapy, targeted drugs that home in on cancer cells, immunotherapy that helps the body’s defenses attack the cancer, radiation therapy, and sometimes a stem cell transplant. For many living with immune system cancer, treatment may happen in phases, such as first bringing the cancer under control and then helping keep it from coming back. Doctors sometimes recommend a combination of lifestyle changes and drugs, and supportive care can also help with pain, infections, fatigue, nausea, and other day-to-day effects during treatment. Not every treatment works the same way for every person, so the best approach is usually made with a cancer specialist who can explain the likely benefits, side effects, and goals of care.
Can you cure Immune system cancer?
Sometimes. Some immune system cancers can be cured, especially if they are found early or respond well to treatment, while others cannot usually be cured but can often be controlled for a long time. Treatment may get rid of the cancer, ease symptoms, slow it down, and help people live longer, using options such as medicines, radiation, or a stem cell transplant, which replaces damaged blood-forming cells.
Non-drug treatment
Living with immune system cancer can affect daily life in many ways, from fatigue and infections to the stress of frequent appointments and testing. Non-drug treatments often lay the foundation for care, especially when the goal is to remove cancer, destroy it in a targeted way, or support the body through treatment. The best plan depends on the exact type of immune system cancer, where it is in the body, and how far it has spread. Not every approach works the same way, and many people receive a mix of treatments rather than just one.
Surgery may be used when immune system cancer is in one area and can be removed safely. This is more common for some lymph node tumors or an enlarged spleen than for cancers spread through the blood.
Radiation uses high-energy beams to target cancer in a specific part of the body. It can help treat one troublesome area, shrink swollen lymph nodes, or ease symptoms such as pain or pressure.
A stem cell transplant replaces blood-forming cells after very intensive treatment has damaged the bone marrow. For some people with lymphoma, leukemia, or myeloma, this can be part of treatment when the disease is hard to control or comes back.
Some slow-growing immune system cancers do not need treatment right away. With careful checkups, blood tests, and scans, doctors can monitor early symptoms of immune system cancer and start treatment if the disease begins to change.
Your genes may have an impact on how drugs work for you
For people living with immune system cancers, inherited differences in their genes can sometimes change how their body breaks down certain cancer medicines, which may affect how well a treatment works or how likely it is to cause side effects like nerve pain, low blood counts, or severe stomach upset. In some cases, doctors may use this kind of genetic information, sometimes called pharmacogenomics, to help choose a safer dose or avoid a medicine that may be harder for the body to handle. Even so, day-to-day treatment decisions are often shaped just as much by the exact type of cancer, a person’s age and overall health, and changes found in the cancer cells themselves.
Pharmacological treatments
Treatment for immune system cancer often depends on the exact type, such as lymphoma, leukemia, or myeloma, as well as your age, overall health, and whether the disease is newly diagnosed or has come back. The drugs used to treat immune system cancer can include standard chemotherapy, targeted medicines, immunotherapy, steroids, and sometimes hormone-like drugs or cell-based treatments. Many people find relief when the right medicine is matched to the cancer subtype and the goals of treatment. In some cases, medicines are combined for a stronger effect or used in stages over time.
Medicines such as cyclophosphamide, doxorubicin, vincristine, bendamustine, and fludarabine are widely used for many blood and lymph cancers. They work by damaging fast-growing cancer cells, though they can also affect healthy cells and cause side effects such as fatigue, nausea, or low blood counts.
Rituximab and obinutuzumab are targeted antibodies often used for B-cell lymphomas and some leukemias. They attach to a marker on cancer cells so the immune system can recognize and clear them more effectively.
Ibrutinib, acalabrutinib, and zanubrutinib are used in several B-cell cancers, including chronic lymphocytic leukemia and some lymphomas. These medicines block growth signals inside cancer cells and are often taken as tablets rather than through a vein.
Venetoclax is used for certain leukemias and lymphomas, often together with other medicines. It helps trigger cancer cell death, but it must be started carefully because some people can develop tumor lysis syndrome when treatment begins.
Genetic influences
Genetics can play a part in immune system cancer, but it is usually only one factor among many. Some people inherit gene changes that make it harder for the body to repair DNA or control how immune cells grow, which can raise the chance of immune system cancer later in life. Family history is one of the strongest clues to a genetic influence. Even so, many people with immune system cancer do not have a clear inherited cause, because the gene changes that drive these cancers often develop over time in the cells themselves and are not passed down from a parent. If several close relatives have had similar blood, lymph, or immune cancers, your doctor may ask about genetic counseling or testing to better understand your family history of immune system cancer. Knowing whether genes are involved can help guide screening, treatment choices, and conversations with relatives.
Is Immune system cancer genetic?
Genetics can matter in immune system cancer, but most cases are not directly inherited. Certain DNA changes may raise risk or shape how the cancer behaves, while others happen during life rather than being passed down.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of being human and are widespread across the population. Most of these changes do not directly affect health and simply contribute to natural differences among people. In many genes, having a change connected with a condition points to a possible link, not a certain diagnosis, especially when several genes and environmental influences play a role. In some situations, though, one well-understood change in a particular gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
Treatment for immune system cancer is often more personal than it first appears, because gene changes can affect both the cancer itself and how your body handles medicine. In many people with immune system cancer, testing the cancer cells can show changes that help doctors choose treatments that are more likely to work, including certain targeted drugs and some immune-based treatments. Your inherited genes can matter too, since they may affect how quickly you break down a drug, how strongly you respond, or how likely you are to have side effects. Genetics is only one factor, but it can be an important one alongside age, other health conditions, liver and kidney function, and the exact type of immune system cancer. If you are discussing genetic testing for immune system cancer treatment, your care team may look at both the cancer’s gene changes and, in some cases, your own drug-response genes to guide safer and more effective care.
Interactions with other conditions
Day to day, people with immune system cancer may find that infections hit harder, last longer, or keep coming back because both the disease and its treatment can weaken the body’s defenses. A simple cold can turn into a chest infection more easily, and illnesses such as flu, shingles, or pneumonia may cause more serious symptoms than expected. Immune system cancer can also complicate long-term conditions like diabetes, heart disease, or kidney disease, because fatigue, poor appetite, anemia, and treatment side effects can make overall health harder to manage. Doctors call it a comorbidity when two conditions occur together. Some treatments for immune system cancer may need to be adjusted if someone also has liver problems, autoimmune disease, or another cancer, and medicines for one illness can sometimes affect another. If you are wondering about the early symptoms of immune system cancer, it is also important to tell your care team about any other health problems, since those can change both symptoms and treatment choices.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Immune system cancer?
Several more common problems can look a lot like immune system cancer at first, especially if someone has swollen glands, fever, night sweats, weight loss, or extreme tiredness. These include infections such as mono, the flu, COVID-19, or tuberculosis, as well as autoimmune illnesses, where the body attacks its own tissues, such as lupus. Some other blood disorders and cancers can also cause similar signs, so doctors usually need blood tests, scans, and sometimes a biopsy to tell them apart.
History
Long before doctors could explain why, people living with immune system cancer were often described as having lasting fatigue, swollen glands, frequent infections, or unexplained weight loss. In older medical writings, these problems were usually grouped with other illnesses because there was no clear way to tell diseases of the blood, lymph nodes, and bone marrow apart. What may now sound like the early symptoms of immune system cancer was once recognized only after someone became very unwell.
By the 1800s, better microscopes began to change that. Doctors could study blood cells and tissue samples more closely, which helped them separate different kinds of cancer affecting the immune system, including cancers of the lymph nodes, blood, and bone marrow. Over time, names and classifications changed as medicine improved, and conditions that once seemed mysterious became easier to identify earlier and more accurately.
Treatment history also moved in steps rather than all at once. In the 20th century, radiation, chemotherapy, and improved supportive care helped more people survive cancers that had once been almost uniformly fatal. In recent decades, awareness has grown, and newer approaches such as targeted medicines, stem cell transplant, and immunotherapy have given many living with immune system cancer more options than earlier generations had.
Researchers later identified that some immune system cancers are linked to changes in cells’ genetic material, though that understanding came well after doctors first recognized the diseases themselves. Today, immune system cancer is still a broad term that includes several different conditions, and their outlook can vary a lot. Looking back helps explain why diagnosis, treatment, and follow-up are now much more tailored to the exact type of cancer and to the needs of each person receiving care.